ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
78 hedge funds and large institutions have $273M invested in Adamas Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 81 → 78 (-3)
Holders
78
Holding in Top 10
3
Calls
$282K
Puts
–
Top Buyers
| 1 | +$9.06M | |
| 2 | +$2.12M | |
| 3 | +$1.64M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$919K |
| 5 |
BWCA
Brenner West Capital Advisors
New York
|
+$882K |
Top Sellers
| 1 | -$3M | |
| 2 | -$2.15M | |
| 3 | -$2.11M | |
| 4 |
BOS
Bingham Osborn & Scarborough
San Francisco,
California
|
-$1.99M |
| 5 |
CPH
C Partners Holding
Zurich,
Switzerland
|
-$973K |